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Introduction
Mutations in the NLRP3 gene are associated with the
dominantly inherited cryopyrin-associated periodic syn-
drome (CAPS) characterized by episodes of fever, urticar-
ial rash, arthralgia, myalgia, eye inflammation, and, in its
more severe forms, bony abnormalities and CNS inflam-
mation. Of the 145 sequence variants in NLRP3 reported
to date, 30 are either nonpathogenic or of undetermined
significance, the commonest of which, Q703K, has been
reported in 5 to10% of general population.
Objectives
To characterize the clinical phenotype in individuals with
Q703K in a single UK center.
Methods
1017 subjects with hereditary periodic fever syndromes
(HPFS) were screened for mutations in the NLRP3 gene,
individuals in whom genetic variants were not identified
or those with low penetrance mutations underwent addi-
tional screening of MEFV; TNFRSF1A; MVK and NOD2.
Results
NLRP3 Q703K was identified in 69 subjects (7% of
screened), clinical information was available on 56.
4 cases had another mutation in NLRP3: 1 had A439V
and 3 siblings had R260W. 18 subjects (32%) had aber-
ration in another HPFS gene: 4 in TNFRSF1A: R92Q,
C29F, H22Q and S57_E64del; 1 in MVK: V377I; 2 in
NOD2: P268S and 12 in MEFV: 2 were compound het-
erozygotes, M680I/V726A and M694V/V726A, 2 were
homozygous and 1 was heterozygous for M694V, 1 was
heterozygous for V726A, 2 for S208C, 1 for S154P and 3
for E148Q.
The inflammatory syndromes were thought to be fully
consistent with CAPS, TRAPS, MKD and FMF in the
4 cases with NLRP3 variants other than Q703K; 4 subjects
with TNFRSF1A mutations; a subject with MVK variant
and 5 of the 12 cases with MEFV substitutions respec-
tively. One subject with Q703K and E148Q was an asymp-
tomatic carrier and in 4 cases a diagnosis of disease other
than HPFS was made. 14 cases (25%) were diagnosed with
AA amyloidosis (confirmed immunohistochemically and
by SAP scintigraphy) the nature of the underlying inflam-
matory disease in 12 remains uncertain. In total we were
unable to make a clinical diagnosis in 25 subjects (44%): in
this group the median age at disease onset was 5 years
(birth-59 years); fever, arthralgia and myalgia were the
most prominent features - identified in over 50% of cases;
11 subjects (44%) had rash during febrile attacks (urticarial
rash was reported in 4); 7 (28%) had symptoms triggered
or worsened by cold exposure; 5 (20%) suffered from
headache, GI symptoms or lymphadenopathy; 4 (16%) had
hearing impairment; a delayed puberty was identified in
4 (16%) and one had growth deficit. Episodes occurred
irregularly and lasted from 1 day to 2 weeks.
In 10 the inflammatory markers, serum amyloid A pro-
tein (SAA) and C-reactive protein (CRP), were measured
during disease flare and were elevated to median values of
106.5 mg/L (range 40-438) and 68 mg/L (range 34 – 220)
respectively.
Conclusion
We have identified Q703K in subjects displaying FCAS-
like symptoms, in individuals with HPFS other than
CAPS, in cases with uncharacterised autoinflammatory
diseases, in AA amyloidosis, and in asymptomatic indivi-
duals. Given the high frequency of healthy carriers, the
interpretation of Q703K presents a diagnostic challenge
and the genetic and/or environmental factors that may
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